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PRESCRIBING PRACTICES IN LONG-TERM CARE:
INVISIBLE INFLUENCES
Diane Feeney Mahoney*, Tammy McNeill**, MJ Henderson***

INTRODUCTION
Adults over age sixty-five are the greatest consumers of
prescription drugs, taking one third of prescription medications
* Diane Feeney Mahoney PhD, ANP, BC, FAAN is the Jacque Mohr
Research Professor in Geriatric Nursing at the MGH Institute of Health
Professions in Boston, Massachusetts. She has been a geriatric nurse
practitioner for over thirty years and is known for her innovations in
geriatric care delivery and intervention research. She has been a
principal investigator in over sixteen funded geriatric studies and has
published over eighty-five original research articles in the fields of
gerontology, geriatrics, nursing, informatics, and gerontechnology.
Her dissertation research focused on the appropriateness of geriatric
prescribing by clinicians, and she has maintained a lifelong interest in
the topic. She is a fellow in both the Gerontological Society of America
and the American Academy of Nursing.
** Tammy McNeill, MSN, ANP-BC, GNP-BC is a geriatric nurse
practitioner in internal medicine at Lawrence Memorial Hospital in
Medford, MA. McNeill monitors geriatric in-patients at the Hospital
and assesses their responses to medications to reduce negative side
effects and delirium. She is a graduate of the MGH Institute of Health
Professions School of Nursing in Charlestown, MA.
*** MJ Henderson has been a Gerontological Nurse Practitioner for 26
years practicing in a variety of clinical settings in the USA. She is very
involved in NP professional organizations serving on boards of
directors and she is a past President of the Gerontological Advanced
Practice Nurses Association. She also serves on editorial and advisory
boards of professional journals and is a sought after speaker both
nationally and internationally. She is an Assistant Professor of Nursing
at the MGH Institute of Health Professions School of Nursing in
Boston, Massachusetts.
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prescribed in the U.S.1 Older adults in long-term care settings
are more likely to be in poorer health than their communitydwelling counterparts. Nursing home residents, on average,
take ten different medications daily for a range of co-morbid
health conditions and still rate their health as either fair or poor.2
The purpose of this paper is to provide an overview of the
existing influences on prescribing patterns in the long-term care
setting, and to inform and alert the legal community about
issues that affect treatment of geriatric clients in these settings.
Older adults are at increased risk for adverse drug events
due to consumption of multiple medications and age-related
physiological alterations in the absorption and elimination of
medications.
Other more invisible influences, such as
pharmaceutical industry marketing techniques, also affect
prescribing practices in long-term care settings. Currently,
pharmaceutical marketing activities are under scrutiny for
influencing consumer demand and physicians’ drug decision
making. The advent of nurse practitioner (NP) prescribers offers
new insights into additional key influences on drug selection
and utilization. Examination of a range of seemingly invisible
influences is explored to bring to light the complexities of
geriatric prescribing in long-term care. (See Figure 1.) Ways to
optimize safe, cost-effective prescribing approaches for older
adults will also be discussed.
AGE-RELATED PHYSIOLOGICAL CHANGES THAT AFFECT
PRESCRIBING
PHARMACODYNAMICS
Pharmacodynamics relates to the physiological and

1. Lisa C. Hutchison, Biomedical Principles of Aging, in FUNDAMENTALS OF
GERIATRIC PHARMACOTHERAPY 53, 62 (Lisa C. Hutchison & Rebecca B. Sleeper eds.,
2010).
2. Richard G. Stefanacci, Medicare Reform’s Impact on Long-Term Care, 5
JAMDA 418, 418 (2004).
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biochemical effects that drugs have on the body.
The
pharmacodynamic properties of prescription drugs are altered
in the older adult due to age-related changes within multiple
body systems.3 For example, the cardiovascular system of the
older adult experiences diminished capacity of the baroreceptors
to respond to drops in blood pressure, making individuals more
susceptible to orthostatic hypotension, and to respond to
lowered blood pressure that can result from changes in posture,
3. See Hutchison, supra note 1, at 63.
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such as standing, that can be exacerbated by many classes of
anti-hypertensive medications.4 The older adult is also more
likely to experience isolated systolic hypertension due to loss of
elasticity of blood vessels, making sudden decreases in blood
pressure even more severe.5
The aging nervous system also contributes to altered
responses to medications in the older adult.6 For instance, an
older adult’s brain has a diminished reserve of
neurotransmitters, and therefore has a diminished capacity to
compensate for changes in response to medications.7
Psychoactive medications that permeate the blood brain barrier
may cause increased concentrations of the drug at the nerve
endings, often manifesting as increased effects even with lower
doses of medications.8 Increased sensitivity to anti-cholinergic
medications, such as antihistamines, can lead to drowsiness and
even major confusion in older adults.9 For this reason, it is
recommended that any initial prescription for these types of
medications be prescribed at the lowest dose and, if necessary,
gradually increased over time to prevent potentially harmful
side effects.
PHARMACOKINETICS
Older adults experience age-related changes that affect
pharmacokinetics—the manner in which drugs are distributed,
metabolized, and excreted—predisposing this population to
possible adverse drug effects. Absorption of medications is
altered due to changes within the gastrointestinal system. Most
drugs are absorbed through passive diffusion in the small
intestine; however, oral and gastric absorption of medication

4.
5.
6.
7.
8.
9.

Id. at 65–66.
Id. at 66.
Id.
Id.
Id.
Id.
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also occurs.10 A slowed transit time between the oral cavity and
small intestine due to decreased peristaltic movement will
decrease absorption.11 A subset of older adults experience
achlorhydria, which is a decreased secretion of hydrochloric
acid.12 Achlorhydria is often found in those who have had peptic
ulcer disease or previous gastric surgery.13 In addition, many
geriatric patients undergo long-term treatment with protonpump inhibitors and histamine-2 blockers for gastroesophageal
reflux disease (GERD), more commonly called heartburn, which
can potentially decrease the absorption of drugs.14
The storage and distribution of drugs in older adults
significantly affects sensitivity and response to medications.
Older adults have a decrease in total body water and lean
muscle mass, and a corresponding increase in body fat
percentage.15 Therefore, hydrophilic (water-loving) medications
have a smaller volume of distribution, and greater effects at
smaller doses.16 This alteration indicates the need to prescribe
the lowest possible medication dose because therapeutic
responses will be seen sooner than in younger adults. Higher
serum concentrations of hydrophilic medications put the older
adult at greater risk for experiencing toxic effects. Similarly,
medications that are distributed into lean muscle mass also have
a smaller volume of distribution.17 One example of such a
medication is digoxin, which slows and strengthens heart
contractions. Digoxin has an average distribution volume of
only three to four liters per kilogram in the geriatric population,
compared to six to seven liters per kilogram in younger adults.18
As a result, digoxin toxicity is common and should be carefully

10.
11.
12.
13.
14.
15.
16.
17.
18.

Id. at 63.
Id.
Id.
Id.
See id.
Id.
Id.
Id.
Id. at 63–64.
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monitored in older adult populations.19
Lipophilic (lipid- or fat-loving) medications pose a unique
problem to older adults, as these medications have the
propensity to accumulate in the body and to be stored for longer
periods of time.20 As the drug accumulates, older adults are
more likely to experience toxic effects. Due to this alteration in
drug distribution, lipophillic benzodiazepines and antipsychotics are two classes of medications that pose higher risk in
the older adult population.21 Many psychotherapeutic agents
also have longer half-lives, which prolong the effects and can
result in older adults progressing through stages of drowsiness,
confusion, delirium, and on to somnolence from the medication
accumulation.22
Older adults who have decreased protein stores, such as
those with hypoalbuminemia, may also experience increased
drug effects. A protein-binding drug that is unbound to a body
protein is the active form of the drug responsible for its effects
on the body. Malnourished and frail elders are the most
susceptible to decreased protein stores and consequent increased
effects from medications.23 Two protein bound medications are
warfarin (blood thinner) and phenytoin (anti-seizure).24
Warfarin is a commonly prescribed anti-coagulant used to
prevent blood clots from forming after heart attacks, valve
replacements, and rapid heart rates, or to prevent existing clots
from growing. Accumulation of this medication can cause
serious bleeding; therefore, the dosage must be carefully
monitored during the entire course of therapy, and all clinicians
involved in treatments need to be informed of its use.25
The liver is one of the major body organs involved in the
19. See, e.g., Kristen Cook & James E. Tisdale, Cardiovascular, in FUNDAMENTALS
GERIATRIC PHARMACOTHERAPY 121, 121, 147 (Lisa C. Hutchison & Rebecca B.
Sleeper eds., 2010).
20. Hutchinson, supra note 1, at 64.
21. Id. (citation omitted).
22. See id.
23. Id.
24. Id.
25. See, e.g., Cook & Tisdale, supra note 19, at147.
OF
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metabolism or breakdown of drugs in the body. The liver in
older adults is often smaller in size and has decreased blood
flow.26 Drugs that are highly metabolized through the liver
must be prescribed at lower dosages because greater
concentrations will be available in the blood stream.27
Decreased excretion of drugs is another age-related change
that must be considered by clinicians prescribing for the older
adult. Kidney size and renal blood flow are reduced in the older
adult, in addition to decreased functioning of the kidney’s
filtration units, the glomeruli.28 Direct measurement of the
glomerular filtration rate (GFR) is not routinely measured in
clinical practice because it requires a 24-hour urine collection
and processing.29 Therefore, it is possible that kidney function in
some older adults may be more diminished than estimated. The
usual standard of practice is to use an estimated GFR that can be
found with a simple blood test, or to determine creatinine
clearance with the Cockcroft-Gault equation.30 The use of the
Cockcroft-Gault equation may be problematic for those with low
muscle mass as the equation may not adequately take into
account the decreased rate of tubular secretion in proportion to
the decreased number of nephrons in the smaller kidney of the
older adult.31 Adults with compromised kidney function carry a
high risk of experiencing increased effects of medications since
they circulate for a longer period of time in the blood before
being filtered out. A number of prescription drugs have specific
guidelines for renal dosing in those with varying degrees of
known renal impairment.32

26. Hutchison, supra note 1, at 64.
27. Id.
28. See id. at 65.
29. Id.
30. Id.
31. Id.
32. For an example of various drugs’ necessary dosage adjustments for
patients with decreased renal function, see David F. McAuley, Renal Dosing
Database, GLOBAL RPH, http://www.globalrph.com/renaldosing2.htm (last visited
Feb. 13, 2012).
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POLYPHARMACY
Polypharmacy, or the use of many medications, is a
common issue in geriatric therapeutics because of the frequency
of multiple chronic diseases that require multi-drug regimens.
Additionally, there is a plethora of what are known as “me-too”
drugs—medications that are often more expensive than their
predecessors but offer no additional treatment benefit, and
which generally have not been tested with frail older adults with
co-existing illnesses.33 The fact that older adults are frequently
excluded from clinical drug trials further contributes to the lack
of knowledge and awareness of polypharmacy effects in the
geriatric population.34
It cannot be overlooked that many chronic diseases such as
hypertension, congestive heart failure, chronic obstructive
pulmonary disease, and diabetes often co-exist and require
multi-drug regimens for therapeutic outcomes.
The
proliferation of some new medications has contributed to
improvements in management options for these illnesses.35
Coupled with the fact that older adults are more at risk of
developing chronic diseases as they age, it can be argued that
polypharmacy can be a necessity.36
Unnecessary polypharmacy, however, can occur due to a
preventable phenomenon known as “prescribing cascade.” This
results from prescribing one medication for one indication, such
as a non-steroidal anti-inflammatory drug (NSAID) for arthritis
pain, which then results in a prescription for a proton-pump
inhibitor when gastric irritation occurs from NSAID use.37

33. See Randall S. Stafford et al., New but Not Improved? Incorporating
Comparative-Effectiveness Information into FDA Labeling, 361 N. ENG. J. MED. 1230,
1231 (2009).
34. See Jerry Avorn, Medication Use in Older Patients: Better Policy Could
Encourage Better Practice, 304 JAMA 1606, 1606–07 (2010).
35. Diane Mahoney et al., Preventing Drug-Drug Interactions Among Older
Adults: Guidelines and Clinical Application, 3 AM. J. NURS. PRAC. 7, 7 (1999).
36. See, e.g., Noel H. Ballentine, Polypharmacy in the Elderly: Maximizing Benefit,
Minimizing Harm, 31 CRITICAL CARE NURS. Q. 40 (2008).
37. Id. at 44.
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Clinicians must be vigilant to avoid treating one drug symptom
with another drug that also produces side effects resulting in
more drug therapies for symptoms that are not diseaseinduced.38 Multiple prescribers from multiple settings also
increase the likelihood of polypharmacy. As patients transition
among generalists and specialists and through primary care,
acute care, rehabilitation, and long-term care settings, redundant
medications can occur.
A medication review to reduce
redundant and unnecessary medications is recommended at
every transfer point in care.
ADVERSE DRUG EVENTS
Adverse drug events (ADEs) include both harm caused by
the drug, such as an adverse drug reaction (ADR) or overdose,
and harm from the use of the drug.39 Unfortunately, ADRs can
occur within normal dosing ranges and regular usage. As stated
previously, older adults are more susceptible to ADEs due to
changes related to normal aging. Because older adults are more
likely to experience chronic diseases that require multiprescription drug regimens, this population is also more likely
to experience side effects and interactions between multiple
medications. ADEs are a significant cause of morbidity and
mortality in the older adult population, as well as one of the top
reasons for admission to the hospital.40 Drug-drug interactions
account for many incidences of ADEs and drug toxicities.41
Identifying ADEs in the older adult poses an even more
difficult problem because older adults often present with vague
symptoms, such as confusion or fatigue, which may actually be

38. See Diane Feeney Mahoney, Innovations in Clinical Practice (ICP) Fast Fact
Sheet, Geriatric Prescribing Guidelines, NAT’L GERONTOLOGICAL NURS. ASS’N, (Jan.
2004) (on file with Nat’l Gerontological Nurs. Ass’n.).
39. Jonathan R. Nebeker et al., Clarifying Adverse Drug Events: A Clinician’s
Guide to Terminology, Documentation, and Reporting, 140 ANNALS INTERNAL MED. 795,
797–798 (2004).
40. Ballentine, supra note 36, at 40.
41. See id. at 45; see also Jerry H. Gurwitz et al., The Incidence of Adverse Drug
Events in Two Large Academic Long-Term Care Facilities, 118 AM. J. MED. 251 (2005).
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signs of a serious ADE. Additionally, the ADE may present long
after the patient has started taking the drug because of the agerelated changes discussed above or the addition of a new acute
condition. Estimates indicate there are approximately 760,000
preventable ADEs annually in nursing homes resulting mainly
from complications of polypharmacy due to indefinite use of
medications beyond their original indications.42
Medication errors refer to mishaps that occur during
prescribing, transcribing, dispensing, or administering a drug.
Not all errors result in ADEs, but they may be classified as “near
misses” or potential for ADE when they are stopped prior to
harm. Medication errors are more common than ADEs, but
result in harm less than 1% of the time.43 ADRs and harmful
medication errors should be documented in the medical record
and pharmacy and therapeutic committee reports. Suspected
severe ADRs should be reported to the FDA’s MedWatch
program.
SUBOPTIMAL PRESCRIBING
Suboptimal prescribing refers to overuse, misuse, or
underuse of medications.44 It can be argued that suboptimal
prescribing can also refer to using medications as the initial
treatment for a condition, rather than considering appropriate
non-drug alternatives.45 In 1991, Dr. Mark Beers and colleagues
published a listing of medications that an expert panel
consensus deemed inappropriate for frail older adults residing
in nursing homes.46 In 1997, the listing was expanded to include
medication therapy in all patients over age sixty-five.47 Beers’

42. See Gurwitz et al., supra note 41, at 256.
43. Nebeker et al., supra note 39, at 797.
44. See Gurwitz et al., Improving Medication Prescribing and Utilization in the
Nursing Home, 38 JAGS 542, 542 (1990).
45. Mahoney et al., supra note 35, at 11.
46. Mark H. Beers et al., Explicit Criteria for Determining Inappropriate Medication
Use in Nursing Home Residents, 151 ARCHIVES INTERNAL MED. 1825 (1991).
47. Mark H. Beers, Explicit Criteria for Determining Potentially Inappropriate
Medication Use by the Elderly: An Update, 157 ARCHIVES INTERNAL MED. 1531, 1532
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criteria deemed a medication inappropriate if its usage and/or
dosage presented potential risks that outweighed potential
benefits.48 The list offers straightforward guidelines for geriatric
prescribing, identifying both harmful medications and
inappropriate dosages. Beers’ list was updated again in 2003.49
The Centers for Medicare and Medicaid Services (CMS) adopted
this list as a guideline for nursing home regulation.50 Wise
prescribers and consultant pharmacists also apply the Beers
listing in practice. Still, in a 2005 study of 157,517 adults over
age sixty-five enrolled in health maintenance organizations
(HMO), it was found that five percent of participants were
prescribed at least one out of the eleven medications in the
“always avoid” category of Beers’ list.51 In 2010, researchers
found mixed results in a review of eighteen interventions that
employed a variety of approaches to improving suboptimal
prescribing in nursing homes.52 Thus, despite the existence and
acceptance of guidelines pertaining to prescribing for the older
adult, suboptimal prescribing continues to be an issue that
requires the careful attention of health care practitioners.53
Similarly, attention is turning to the enhancement of
palliative care efforts by relieving pain and increasing comfort
for nursing home residents with advanced dementia. By expert
panel consensus, medications have been identified and deemed
“never appropriate” for treatment of advanced dementia when
the goal of treatment is palliative care.54 And yet, in a recent
(1997).
48. Id.
49. Donna M. Fick et al., Updating the Beers Criteria for Potentially Inappropriate
Medication Use in Older Adults, 163 ARCHIVES INTERNAL MED. 2716 (2003).
50. Ann S. Luggen, Pharmacology Update: Inappropriate Prescribing in the LongTerm Care Setting, 26 GERIATRIC NURS. 233 (2005).
51. Steven R. Simon, et al., Potentially Inappropriate Medication Use by Elderly
Persons in U.S. Health Maintenance Organizations, 2000–2001, 53 JAGS 227, 228, 230
(2005).
52. Zachary A. Marcum et al., Interventions to Improve Suboptimal Prescribing in
Nursing Homes: A Narrative Review, 8 AM. J. GERIATRIC PHARMACOTHERAPY 183, 183
(2010).
53. See Hedva Barenholtz Levy et al., Beyond the Beers Criteria: A Comparative
Overview of Explicit Criteria, 44 ANNALS PHARMACOTHERAPY 1968, 1968 (2010).
54. See Holly M. Holmes et al., Integrating Palliative Medicine into the Care of
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study of nursing home residents with advanced dementia,
thirty-seven percent received at least one of the medications
considered never appropriate, with modest reductions in dosage
or usage occurring only during the last week of life.55 In a
separate study, forty-four percent of nursing home residents
who reported pain received neither standing orders for pain
medication nor special services for pain management.56 Nonwhite residents and those with dementia were less likely to
report or show signs of pain than white residents or those
cognitively intact, respectively.57 Efforts are underway to
improve pain management. In 2009, CMS promulgated F309, a
guideline pertaining to quality of care related to pain assessment
and management.58 Additionally, the Center for Nursing
Excellence in Long-term Care now offers free access to their
website’s evidence-based tools and best practices for assessment
and management of pain in older adults—an invaluable tool for
nurses who work in nursing homes.59 Future research is
warranted to determine the effects of these approaches.
GERIATRIC PRESCRIBERS AND INFLUENCES ON THEIR
TREATMENT DECISION MAKING
With the burgeoning aging population, the need for clinicians
with specialized training in geriatric prescribing is more relevant
than ever. However, specialized training in geriatric prescribing
remains a critical piece still missing from many medical, dental,
Persons with Advanced Dementia: Identifying Appropriate Medication Use, 56 JAGS 1306,
1306 (2008).
55. Jennifer Tjia et al., Daily Medication Use in Nursing Home Residents with
Advanced Dementia, 58 JAGS 880, 880 (2010).
56. Manisha Sengupta, Prevalence and Management of Pain, by Race and Dementia
Among Nursing Home Residents: United States, 2004, U.S. DEP’T HEALTH & HUM.
SERV., NCHS DATA BRIEF, no. 30, Mar. 2010, at 2.
57. Id. at 4.
58. CMS Releases Pain Management Guidelines for Nursing Homes Under F309,
HCPRO (Apr. 16, 2009), http://www.hcpro.com/LTC-231585-4564/CMS-releasespain-management-guidelines-for-nursing-homes-under-F309.html.
59. THE CENTER FOR NURSING EXCELLENCE IN LONG-TERM CARE,
http://www.centerfornursingexcellence.org (under “Resources” click “Geriatric
Pain Website”).
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and osteopathic education programs in the United States.60
Required courses in geriatrics are absent or limited in most
medical schools, and many trainees emerge into practice with a
poor understanding of pharmacotherapeutics in older adults.61
Formal medical training continues to emphasize the mechanisms
of disease and diagnostics, with inadequate attention paid to the
nuances of prescriptive and non-prescriptive therapies for older
adults.
The newest prescriber group is advanced practice registered
nurses (APRNs), which encompasses more than 150,000 nurse
midwives, psychiatric or mental health clinical specialists, and
nurse practitioners (NPs). In the nursing home setting, most
NPs are certified as either adult and/or gerontological NPs. NPs
receive additional education in their specialty, usually at the
Master’s or Doctoral level, and after passing a national
certification exam they are authorized per individual state
regulations to practice and prescribe.62
Numerous studies have documented the effectiveness of
NPs’ management of complex patients in a variety of clinical
settings. NPs are educated to examine the geriatric patient as a
whole person, that is, not only looking at an individual’s medical
information, but also their social, psychological, and mental
health and health behaviors as well as economic status and
cultural beliefs. Initial research on NP prescribers found they
were significantly less likely than physicians to write a
suboptimal prescription for a condition when a non-drug
alternative or lifestyle recommendation was considered more
appropriate.63 When the first nurse-developed guidelines for
geriatric prescribing were published in 1999, practitioners were
instructed to first consider treatment by a non-drug alternative

60. Avorn, supra note 34, at 1606.
61. Id.
62. For a state-by-state comparison of NP legislation, including NP licensure
requirements, see the annual Pearson Report. Linda J. Pearson, The Pearson Report, 15
AM. J. NURSE PRAC., Mar. 2011, available at http://www.pearsonreport.com.
63. See Diane Feeney Mahoney, Appropriateness of Geriatric Prescribing Decisions
Made by Nurse Practitioners and Physicians, 26 J. NURS. SCHOLARSHIP 41 (1994).
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therapy and assess whether new symptoms were attributable to
present drug therapies.64 The current version offers four
recommendations prior to introducing a new drug therapy and
nine recommendations to assist in balancing the risks and
benefits and educating patients and their caregivers about their
medications.65
Recent research suggests that APRNs in primary care are
increasingly targeted by pharmaceutical promotions, and some
APRNs reflect physicians’ positive attitudes towards marketing
efforts by favoring brand name drugs when lower cost generics
are available.66 This research was conducted with NPs from
primarily ambulatory settings. A review of the research
literature found only one study of gerontological NPs’
prescribing patterns; this study reported that gerontological
NPs’ prescribing practices were more influenced by practice
setting than by their age, education, and years of practice.67
Although inappropriate prescribing according to the Beers
criteria was minimal, it was more likely to occur in ambulatory
office-based settings rather than long-term care settings.68 The
reasons for this discrepancy were speculative. Given the lack of
clarity about influences on NPs’ choice of drug therapy,
gerontological NPs in attendance at a national meeting were
recruited to participate in one of two focus groups conducted to
increase understanding about the influence of their practice
setting and other factors on their prescribing patterns.69 Several
key influences were identified.
Foremost the NPs acknowledged that their practice setting,

64. Mahoney et al., supra note 35, at 12; Mahoney, supra note 38.
65. Mahoney, supra note 38.
66. Elissa C. Ladd, Diane Feeney Mahoney & Srinivas Emani, “Under the
Radar”: Nurse Practitioner Prescribers and Pharmaceutical Industry Promotions, 16 AM. J.
MANAGED CARE e358 (2010).
67. Laurie Kennedy-Malone et al., Prescribing Patterns of Gerontological Nurse
Practitioners in the United States, 20 J. AM. ACAD. NURS. PRAC. 28, 31‒32 (2008).
68. Id. at 33.
69. Diane Feeney Mahoney & Elissa Ladd, More than a Prescriber: Gerontological
Nurse Practitioners’ Perspectives on Prescribing and Pharmaceutical Marketing, 31
GERIATRIC NURS. 17 (2010).
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including the type of patient served and the degree of autonomy
they had in choosing medications, made a difference in their
prescribing patterns.70 Office-based NPs were constrained
beyond the usual practice regulations by the office drug
protocols established by their employing physician(s).71 Overall,
NPs took into consideration whether the patient was at home
alone and able to independently take and remember their
medications, or whether there were other caregivers who could
reliably administer medications.72 They were knowledgeable
about the affordability and insurance coverage for medications,
and sensitive to ways to enable adherence to therapies.73 NPs
had to educate and counsel families and patients who
demanded drugs advertised on television, mistakenly believing
the drugs would rectify chronic medical problems.74 Assessing
drug necessity versus using a nondrug alternative was every
NP’s starting point, with clear sensitivity to geriatric drug
dosing, polypharmacy, and pharmacokinetics.75 The nurses
participating in the study highlighted the geriatric dilemma
inherent in evidence-based practice recommendations that are
based on “research [that] did not include geriatric patients,
generic drugs, or attention to quality-of-life issues.”76 Another
dilemma presented itself when their supervising physician’s
protocol did not follow evidence-based guidelines and therefore
precluded the NPs from prescribing the “better” agent.77
Attending to drug reimbursement issues took considerable time
and advocacy with insurers and in many cases the NPs
recommended the commercial four-dollar drug plans because of
better affordability and improved likelihood of purchase.78
When asked about pharmaceutical marketing and drug
70.
71.
72.
73.
74.
75.
76.
77.
78.

See id. at 21.
Id.
Id.
Id.
Id. at 21‒22.
See id. at 20.
Id.
Id. at 21.
Id.
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detailing, the NPs viewed those activities as providing
information but not education.79 Clear skepticism about drug
representatives presenting biased information was prevalent.
Concerns also arose about prescribers being pressured to
prescribe a certain drug because a pharmaceutical company
gave the institution a “good deal” on purchasing it.80 When the
patients transitioned into a facility that did not get the same
good deal, they had to be switched to that facility’s offerings.81
The NPs also identified several “costs” associated with free
samples including an unintended impression on patients that
brand name drugs were superior to generics.82 In long-term care
facilities, medications are provided by pharmacies in thirty-day
packs. The NPs noted it was common to try several medications
to find the best one for a patient’s particular situation. When the
drug was changed after a week-long trial, many facilities
discarded the remaining medication as waste.
NPs’ preferred sources of drug information, after the
professional drug literature, were geriatric physicians and
consulting geriatric pharmacists.83
The latter were most
desirable to aid in complex cases with multi-drug, multi-disease
geriatric patients experiencing compromised renal and liver
functioning.84 Comments portrayed the NPs role as multifaceted, offering more than just being a prescriber. “Lifestyle
counseling, care coordination, drug reviews and reductions,
quality-of-life considerations, family and patient teaching, and
nondrug treatment alternatives all remained equally important
aspects” of the NPs’ offerings.85 Therapy was tailored according
to the “patients’ biophysical, psychological, and economic needs
with an involvement in the interplay of geriatric care issues not

79.
80.
81.
82.
83.
84.
85.

Id.at 22.
Id. at 23.
Id.
See id.
Id. at 24.
See id. at 23.
Id. at 26.
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typically addressed by primary care physicians.”86 Nonetheless,
influences on NPs’ ability to prescribe and practice according to
the full scope of practice were identified as limitations to
improving geriatric care.
STATE AND FEDERAL REGULATIONS
The major external influences on prescribing in long-term
care are federal and state regulation. The Omnibus Budget
Reconciliation Act (OBRA), implemented in 1990, requires that
the facility provide each patient with care that will enable the
patient to “attain or maintain the highest practicable physical,
mental, and psychosocial well-being . . . .”87 Since then, it has
been the U.S. Centers for Medicare and Medicaid Services’
(CMS) responsibility for overseeing the implementation of this
legislation.
For nursing homes to be certified to participate in the
Medicare and Medicaid programs, pharmacists are required to
review the appropriateness of residents’ medications on a
monthly basis, and to recommend changes to providers when
indicated. Additionally, each facility is required to complete the
Minimum Data Set (MDS), a standardized tool to monitor and
track residents’ functional abilities and progression or decline in
relation to their diagnoses and treatments.88 Registered nurses
or case managers hired by the facility are responsible for
completing the MDS for each resident on a quarterly basis, or
whenever there is a change in the resident’s condition. Facilities
are subject annually to unannounced external reviews by CMS
sponsored state surveyors who assess compliance to regulations,
identify deficiencies, and mandate improvements if necessary.89

86. Id.
87. 42 U.S.C. § 1395i-3(b)(2) (section remains unchanged from enactment in
1988 to present).
88. See generally Nursing Home Quality Initiatives, CTRS. MEDICARE & MEDICAID
SERV., http://www.cms.gov/NursingHomeQualityInits (last visited Feb. 22, 2012).
89. Posting of facilities’ ratings can be found at Nursing Home Compare,
http://www.Medicare.gov/NHcompare (last visited Feb. 22, 2012).
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ADVOCATING TO PROMOTE MORE APPROPRIATE PRESCRIBING
IN LONG-TERM CARE
REDUCE THE IMPACT OF PHARMACEUTICAL MARKETING ON
PRESCRIBERS.
The pharmaceutical industry spent $20.5 billion in 2008 to
promote name brand prescription drugs.90 Of this, $12 billion
was spent to detail physicians, NPs, and physician assistants;
$3.4 billion to sponsor professional meetings and events; $400
million to advertise in professional journals; and $4.7 billion to
advertise direct-to-consumers (DTC).91
The Institute of Medicine (IOM) issued a report that
addressed the role of funding from pharmaceutical and medical
device companies to support professional continuing education
programs.92 The report stated that such funding inherently
creates conflicts of interest and recommends redesigning
continuing education in the health professions to reduce
dependency on these industries.93 From the federal legislative
perspective, physician payment sunshine provisions were
included in the Patient Protection and Affordable Care Act of
2009 (PPACA or ACA), which was signed into law on March 23,
2010 but implemented only recently.94
These sunshine
provisions mandate the disclosure of gifts and payments over
ten dollars to physicians and teaching hospitals by
“manufacturers,” including pharmaceutical and medical device
companies.95

90. CONG. BUDGET OFF., ECON. & BUDGET ISSUE BRIEF, PROMOTIONAL
SPENDING FOR PRESCRIPTION DRUGS 2 (Dec. 2, 2009).
91. Id. at 1–2.
92. INST. MED. NAT’L ACAD., REDESIGNING CONTINUING EDUCATION IN THE
HEALTH PROFESSIONS 4, 69–72 (2009), available at http://www.iom.edu/Reports/2009/
Redesigning-Continuing-Education-in-the-Health-Professions.aspx (download free
full report in right navigation pane).
93. Id. at 4, 69–72.
94. 42 USC § 1320a-7h (2009).
95. See id. at § 1320a-7h (e)(10)(B)(i). These disclosure reports should be publicly
available online by September 30, 2013. Id. at § 1320a-7h (c)(1)(C).
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At the state level, Vermont previously placed a ban on
pharmaceutical companies providing free meals96, and
Massachusetts limits meals to purchases in a hospital setting and
requires disclosure of any gift greater than fifty dollars.97 The
Harvard affiliated hospitals recently enacted stringent policies
on their staff, including clinical researchers who were not
addressed under the legislation. This movement has caused a
backlash among businesses, including hospitals, that benefited
from pharmaceutical-sponsored events and which now claim
loss of critical revenue during an economic recession.
Lawmakers sought unsuccessfully to repeal the Massachusetts
bill.98
The Pew Prescription Project, created by the Pew Charitable
Trusts, is an initiative “to promote consumer safety through
reforms in the approval, manufacture, and marketing of
prescription drugs, as well as through initiatives to encourage
evidence-based prescribing.”99 The Project conducted a review
of the published studies on academic detailing, or individual
prescriber education programs to physicians, which provide
unbiased drug information and drug cost comparisons.100 While
the potential for improved care and cost savings existed, most
programs were limited by short-term funding that hampered
longer-term behavioral changes in prescribing practices.101
96. 18 VT .STAT. ANN. tit. 18 §§ 4631a(a)(5)(B), (b)(1) (2012).
97. Jacob Goldstein, Massachusetts Bans Industry Gifts to Docs, WALL ST. J.
HEALTH BLOG, (Mar. 12, 2009, 10:21 AM), http://blogs.wsj.com/health/2009/03/12/
massachusetts-bans-industry-gifts-to-docs/.
98. Katherine Hobson, Lawmakers Propose Banning the Mass. Physician Gift Ban,
WALL
ST.
J.
HEALTH
BLOG,
(June
25,
2010
1:01
PM),
http://blogs.wsj.com/health/2010/06/25/lawmakers-propose-banning-the-massphysician-gift-ban/; Katherine Hobson, Follow-Up: Massachusetts Gift Ban Won’t Be
Repealed, WALL ST. J. HEALTH BLOG, (Aug 2, 2010, 3:58 PM),
http://blogs.wsj.com/health/2010/08/02/follow-up-massachusetts-gift-ban-wont-berepealed/.
99. About
Us:
Project
Overview,
PEW
PRESCRIPTION
PROJECT,
http://www.prescriptionproject.org/about (last visited Feb. 24, 2012).
100. Cost-Effectiveness of Prescriber Education (“Academic Detailing”) Programs,
PEW PRESCRIPTION PROJECT REPORT 1 (Mar. 12, 2008), available at http://www.
PrescriptionProject.org/tools/initiatives_reports/files/Final-AcademicDetailing_Cost
Effectiveness_Analysis_3-12-2008_CB.pdf (last visited Feb. 24, 2012).
101. See id. at 4‒5.
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CONTINUE THE USE OF PHARMACEUTICAL PENALTY FUNDS TO
SUSTAIN RESEARCH AND DEMONSTRATION PROJECTS THAT
IMPROVE MEDICATION DECISION MAKING AND REDUCE DRUG
COSTS.

Pharmaceutical penalty funds can be created when drug
manufactures are ordered to pay substantial fines for violating
laws that protect consumers.
On May 13, 2004, Warner-Lambert, a division of Pfizer,
Inc., entered into an Assurance of Voluntary
Compliance/ Discontinuance with the Attorneys
General of 50 States and the District of Columbia to
settle allegations that Warner-Lambert conducted an
unlawful marketing campaign for the drug Neurontin®
that violated state consumer protection laws. Among
other things, the settlement provides for a $21 million
Consumer and Prescriber Education grant program to
be administered by a Special Committee of State
Attorneys General pursuant to an Oregon Court
Order.102
Through this endeavor, several key initiatives have been
developed to increase prescriber’s skepticism about drug
promotional activities and use of evidence-based drugs.
On the consumer education side, Consumers Union
implemented Best Buy Drug reports to provide free web-based,
unbiased descriptions and comparisons among common
medications including their brand and generic costs.103 After its
creation, the program was featured in Consumers Union’s
publication and highlighted the most common drugs with
generic savings as well as national locations for four dollar
generics.104 This information is critical for consumers because of
102. Consumer & Prescriber Grant Program, http://www.consumerprescriber
grantprogram.org/ (last visited Feb 24, 2012); In the matter of Warner-Lambert
Company LLC, Assurance of Voluntary Compliance, ¶ 27, available at
http://www.consumerprescribergrantprogram.org/files/Assurance_of_Voluntary_
Compliance.pdf
103. Best Buy Drug Reports, CONSUMER RPTS. BEST BUY DRUGS,
http://www.consumerreports.org/health/best-buy-drugs/index.htm.
104. Best Buy Drugs, CONSUMER REPORTS MAGAZINE, Mar. 2011, at 24‒27,
available at http://www.consumerreports.org/cro/magazine-archive/2011/march/
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the great number of “me-too” drugs. There is often a lack of
evidence available comparing the “me-too” drugs to their
predecessors because higher profits results from developing and
marketing more expensive new drugs. This profit motive has
been seen in the advent of new selective-serotonin reuptake
inhibitors (SSRIs), despite the fact that older, generic drugs in
this class are often better and cheaper alternatives.105 As
Consumer Reports noted, many heartburn sufferers now go
immediately to powerful proton pump inhibitors (PPIs) when
studies have shown sixty-nine percent of them do not need PPIs,
but could be treated by lifestyle changes such a modifying their
eating habits or using inexpensive antacids.106 Should a PPI be
necessary, consumers can save $184 a month by using a generic
omeprazole instead of Nexium® (esomeprazole magnesium).107
Successful efforts to provide unbiased objective drug
information to consumers and prescribers should be sustained
and financially supported by pharmaceutical fines.
SUPPORT THE INSTITUTE OF MEDICINE’S (IOM)
RECOMMENDATIONS ON NP PRACTICE.
The first recommendation of the IOM is “Nurses should
practice to the full extent of their education and training.”108 The
practice rules that define the NPs’ permissible activities,
including prescriptive authority, vary widely because licensing
and regulations vary among the states. A nurse can or cannot
prescribe certain classes of drugs by virtue of where he or she
resides and whether the NP has a supervising or collaborative
relationship with physicians. Thus, the NPs’ skillset in the
marketplace is limited not by their education, credentialing, or
health/ best-buy-drugs/overview/index.htm.
105. See id. (click “Depression” in navigation pane).
106. Id. (click “Heartburn” in left navigation pane).
107. See id.
108. INST. MED. NAT’L ACAD., THE FUTURE OF NURSING: LEADING CHANGE,
ADVANCING HEALTH 2 (2010), available at http://www.iom.edu/Reports/2010/TheFuture-of-Nursing-Leading-Change-Advancing-Health.aspx (download free full
report in right navigation pane) [hereinafter “THE FUTURE OF NURSING”].
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practice competencies, but by the unique state laws and office
policies where they work. The IOM recommends that state
scope of practice laws be reformed to remove unduly restrictive
barriers to NP practice.109
Broad based coalitions began
developing in 2011 to pursue changes in restrictive state and
federal legislation over the NP scope of practice as well as anticompetitive and anti-trust laws. Support for these endeavors
will remove undue restrictions on NP services and bring more
NP specialists caring for older adults into nursing homes.
ADDRESS THE ISSUES RAISED BY THE NPS IN LONG-TERM CARE.
NPs advocate for increased access to gero-psychiatric
prescribers—especially consultant geriatric pharmacists—and
coverage for remote consultations and new electronic ways of
communicating with prescribers. NPs also support reductions
in drug costs and drug waste. Most pharmacies dispense in 30day quantities because prescription drug plans pay for 30-day
supplies; however, recent legislative changes in Medicare Part D
will enable beneficiaries in long-term care facilities to have drugs
dispensed in 7-day or fewer quantities, thereby encouraging
titration and reducing waste from unused and costly
medications. If drug deals exist, geriatric advocates should
pursue equitable provisions for consumers such as bulk buying
opportunities for families or nursing home collectives, and the
use of evidence-based, lower cost generic drugs when possible.
ADVOCATE FOR ELECTRONIC HEALTH RECORDS THAT OFFER
MEANINGFUL DRUG THERAPY REVIEWS AND MEDICATION
TRACKING ACROSS THE TRANSITIONS IN CARE SETTINGS.

As new technologies move into health care and long-term
care, providers and the public need to demand programs that
extend beyond administrative record keeping and actually carry
the potential to improve the quality of care. Prescribers should

109. Id. at 1.
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have access to in-house programs that conduct preliminary drug
reviews, link to relevant guidelines, and incorporate
comparative drug cost and efficacy data. These programs
should offer online geriatric pharmacy consultations and export
and import data when the patient transitions across other health
care settings. In the future, long-term care can benefit from the
development of a device similar to an “IBM Watson”110 for
nursing home therapeutics. This device would input individual
data, weigh the relevant factors, and provide the cost-benefit
scenarios for the appropriate range of therapeutic options. Until
then, all providers have critical roles to play in ensuring the
welfare and safety of older adults.

110. For information about IBM Watson and how this technology may be
applied in the healthcare field, see the video clip at Healthcare, IBM WATSON,
http://www.ibm.com (under Popular Links, click Watson > Watson for a Smarter
Planet > Industry Perspectives > Healthcare).

